Literature DB >> 8834480

Mechanisms in the pathogenesis of amiodarone-induced pulmonary toxicity.

T E Massey1, R G Leeder, E Rafeiro, J F Brien.   

Abstract

Although amiodarone is a highly efficacious antidysrhythmic agent, the drug produces numerous adverse effects. The most critical of these is pulmonary toxicity because of the potential for mortality. This review examines the experimental model systems used to study amiodarone toxicity, summarizes the current state of knowledge regarding the processes involved in amiodarone-induced pulmonary toxicity (AIPT), and includes a discussion of potential future directions. Possible contributing processes to initiation of AIPT include phospholipidosis, altered calcium ion regulation, generation of reactive oxygen species, formation of an amiodarone aryl radical, and perturbation of cellular energy production. In addition, an immune response to the parent compound or to a metabolite could play a role. It is expected that elucidation of the mechanism(s) of AIPT will lead to safer antidysrhythmic agents and (or) to effective treatments for the prevention or amelioration of AIPT.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8834480     DOI: 10.1139/y95-730

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  9 in total

Review 1.  Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?

Authors:  Martin Schwaiblmair; Thomas Berghaus; Thomas Haeckel; Theodor Wagner; Wolfgang von Scheidt
Journal:  Clin Res Cardiol       Date:  2010-07-10       Impact factor: 5.460

Review 2.  Amiodarone: review of pulmonary effects and toxicity.

Authors:  Spyros A Papiris; Christina Triantafillidou; Likurgos Kolilekas; Despoina Markoulaki; Effrosyni D Manali
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

3.  Role of vitamin-E on rat liver-amiodarone: an ultrastructural study.

Authors:  Mohamed Samir A Zaki; Refaat A Eid
Journal:  Saudi J Gastroenterol       Date:  2009-04       Impact factor: 2.485

Review 4.  [Amiodarone-induced pulmonary toxicity].

Authors:  A Heisel; M Berg; M Stopp; D Ukena; H Schieffer
Journal:  Med Klin (Munich)       Date:  1997-12

Review 5.  Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.

Authors:  Osamu Matsuno
Journal:  Respir Res       Date:  2012-05-31

6.  Boswellic acids extract attenuates pulmonary fibrosis induced by bleomycin and oxidative stress from gamma irradiation in rats.

Authors:  Eman Noaman Ali; Somaya Zakaria Mansour
Journal:  Chin Med       Date:  2011-09-30       Impact factor: 5.455

7.  Acute Amiodarone Pulmonary Toxicity after Drug Holiday: A Case Report and Review of the Literature.

Authors:  Ahmed Abuzaid; Marwan Saad; Mohamed Ayan; Amjad Kabach; Toufik Mahfood Haddad; Aiman Smer; Amy Arouni
Journal:  Case Rep Cardiol       Date:  2015-05-14

8.  A multicenter retrospective cohort study on predicting the risk for amiodarone pulmonary toxicity.

Authors:  Wang Chun Kwok; Ting Fung Ma; Johnny Wai Man Chan; Herbert H Pang; James Chung Man Ho
Journal:  BMC Pulm Med       Date:  2022-04-05       Impact factor: 3.317

9.  Assessment of lung toxicity caused by bleomycin and amiodarone by Tc-99m HMPAO lung scintigraphy in rats.

Authors:  G Gumuser; K Vural; T Varol; Y Parlak; I Tuglu; G Topal; E Sayit
Journal:  Ann Nucl Med       Date:  2013-04-05       Impact factor: 2.668

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.